✦ LIBER ✦

Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells

✍ Scribed by Hiroki Kawamura; Hideo Yagita; Tetsuro Nisizawa; Nakako Izumi; Chikako Miyaji; Russell E. Vance; David H. Raulet; Ko Okumura; Toru Abo

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 483 KB
Volume: 35
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.200425933

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Normal IgG protects against acute graft-

Normal IgG protects against acute graft-versus-host disease by targeting CD4+CD134+ donor alloreactive T cells

✍ Laure Caccavelli; Anne-Christine Field; Virginie Betin; Laetitia Dreillard; Mari 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Regulation of graft-versus-host-reaction

Regulation of graft-versus-host-reaction by Mlsa-reactive donor T cells

✍ Satish C. Muluk; Frances T. Hakim; Gene M. Shearer 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

FTY720 enhances the activation-induced a

FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease

✍ Daigo Hashimoto; Shoji Asakura; Ken-ichi Matsuoka; Yukimi Sakoda; Motoko Koyama; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

Control of graft-versus-host disease by

Control of graft-versus-host disease by regulatory T cells: Which level of antigen specificity?

✍ Marianne M. Martinic; Matthias G. von Herrath 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Improved survival from potentially letha

Improved survival from potentially lethal graft-vs.-host disease by donor pretreatment with a recipient-specific blood transfusion. II. Evidence for a principal role of the CD4+ T cell subset

✍ Andre C. Knulst; G. John M. Tibbe; Clara Bril-Bazuin; Robbert Benner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets